Shuli Xia received her Ph.D. degree in biology (summa cum laude) in 1998 from Institute of Physiologic Chemistry and Pathology Biochemistry, Johannes-Gutenberg University, Mainz, Germany. She studied the role of glutamate receptors in neural development during her Ph.D. thesis work. She was a Postdoctoral Fellow at Washington University School of Medicine, Yale University, and John Hopkins, from 1999 to 2005. She worked on various projects including neurotoxicity, RNA editing, and apoptosis. Since 2006, she is a Faculty Member at the Department of Neurology, Hugo W. Moser Research Institute at Kennedy Krieger and the John Hopkins University School of Medicine. Currently, she serves as an Assistant professor, and she is mainly interested in brain cancer research, including apoptosis in tumor cells induced by chemotherapeutic drugs, differentiation therapy of brain cancer stem cells, tumor invasion, and angiogenesis.
Biography Updated on 4 December 2011